๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Oral Squamous Cell Carcinoma (OSCC)
Clinical trial register · China

Oral Squamous Cell Carcinoma (OSCC) Trials in China, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Guangzhou 5 Shanghai 5 Kunming 1
Narrow the registerReset
Recruitment status
Phase
Site location
Guangzhou5 Shanghai5 Kunming1
All 3 locations
Target enrolment
to

Oral Squamous Cell Carcinoma (OSCC) trials in China

11 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Neoadjuvant Sintilimab Plus Chemotherapy for cT2N0M0 Oral Squamous Cell Carcinoma
NCT07827872Oral Squamous Cell Carcinoma (OSCC), Head and Neck Squamous Cell Carcinoma, Early-stage Oral Cancer
caohaotian
Phase 3
300
Guangzhou
2026-10-01
Not yet open
Rimegepant-Sensitized Neoadjuvant Chemoimmunotherapy for Oral or Oropharyngeal Squamous Cell Carcinoma
NCT07812467Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (OPSCC)
Shanghai Zhongshan Hospital
Phase 2
220
Shanghai
2026-10-01
Not yet open
Discovery and Validation of Biomarkers for Periodontitis, Dental Caries and Oral Squamous Cell Carcinoma
NCT07745803Oral Squamous Cell Carcinoma (OSCC), Periodontal Disease, Dental Caries
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Observational
4,000
Shanghai
2026-08-25
Recruiting
Sintilimab Plus Chemotherapy as Neoadjuvant and Adjuvant Treatment for Locally Advanced Oral Squamous Cell Carcinoma
NCT07371611Locally Advanced Oral Squamous Cell Carcinoma, Oral Squamous Cell Carcinoma (OSCC)
Qunxing Li,MD
Phase 3
104
Guangzhou
2026-01-01
Not yet open
Neoadjuvant and Adjuvant Sintilimab Plus Cetuximab in Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma
NCT07079410Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma, Resectable Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
50
Shanghai
2025-07
Not yet open
Chemoimmunotherapy With or Without SBRT Before Surgery for Locally Advanced Oral and Oropharyngeal Cancer
NCT06861712Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Stereotactic Body Radiation Therapy (SBRT)
Sun Yat-sen University
Phase 2
50
Guangzhou
2025-05-06
Recruiting
Trop2-targeting NIR-II Molecular Probe for Precision Diagnosis of Oral Cancer
NCT07794813Oral Squamous Cell Carcinoma (OSCC), Diagnosis
Yunnan Cancer Hospital
Observational
40
Kunming
2024-12-03
Not yet open
Preoperative Tislelizumab -Cetuximab - Chemotherapy Followed by Salvage Surgery and Adjuvant Tislelizumab -Cetuximab for Resectable, Locally Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
NCT06728618Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC), Resectable Oral and Oropharyngeal Squamous Cell Carcinoma, Recurrent Oral and Oropharyngeal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital
Phase 2
28
Shanghai
2024-12
Not yet open
Clinical Outcomes of Thoracodorsal Artery Flap in Oral and Maxillofacial Reconstruction
NCT06599801Oral Squamous Cell Carcinoma (OSCC)
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
217
Guangzhou
2024-09-30
Recruiting
A Bidirectional Observational Clinical Study of NAIC in the Treatment of Tumor Regression Patterns in LA-OSCC and LA-OPSCC
NCT07133958Oral Squamous Cell Carcinoma (OSCC), Oropharyngeal Squamous Cell Carcinoma (SCC)
Zhujiang Hospital
Observational
35
Guangzhou
2023-07-11
Rows per page Showing 1–11 of 11
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 25 September 2026. https://priyalifescience.com/clinical-trials-china/condition/oral-squamous-cell-carcinoma-oscc

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 11 of those studies listing the condition Oral Squamous Cell Carcinoma (OSCC).

How many Oral Squamous Cell Carcinoma (OSCC) trials are recruiting in China?

3 of the 11 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 8 have not yet opened recruitment, 0 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Oral Squamous Cell Carcinoma (OSCC)), 11 studies
PhaseStudiesRecruitingShare
Phase 25045.5%
Observational4236.4%
Phase 32118.2%

Most active sponsors

Lead sponsors with the most studies (Oral Squamous Cell Carcinoma (OSCC))
Lead sponsorStudiesRecruiting
Shanghai Zhongshan Hospital30
caohaotian10
Qunxing Li,MD11
Shanghai East Hospital10
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University10
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University10
Sun Yat-sen University10
Yunnan Cancer Hospital11
Zhujiang Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.